Orthocell Limited

A$0.57As of Sun 8 Nov 2026, 12:00 UTC
ASX:OCCHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 2.48%
Div yield —
ROE (56.82%)
Biotechnology
Beta (5Y) (0.03)
PE TTM —
TSR TTM (50.64%)
Mkt cap A$156.6M
ROIC (45.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.613
6.55%
(91.62%)
Hold 2|6|1|8|3
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
(6.91%)
4.66%
10.82%
18.90%
Revenue$M
8.681
8.838
8.908
9.084
12.50%
14.19%
11.46%
9.11%
Peers (US$107.6M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.335
0.180
0.170
EBIT/Intx
0.311
0.053
0.065
Own earn%
(44.23)
(85.78)
(102.47)
Sh yield%
27.36
21.37
22.35
Owners
Insiders/Inst%
9.38
89.37
Short interest%
5.42
SBC / revenue%
4.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
20–26
$1 testx
—
Incr. ROIC%
4